Skip to content

European HIV Drug Resistance Workshop: epidemiology

HIV infection, viral load and injecting drug use linked to early signs of cardiovascular disease

High viral load and symptoms of primary infection mean worse survival, says study conducted in HIV-positive sex workers in Kenya

Starting treatment with efavirenz causes only modest changes in sleep patterns

How frequently are ARV side-effects being seen in resource-limited settings, and how are they dealt with?

Differing predictors of resistance to atazanavir/ritonavir or Kaletra identified

US government watchdog criticises PEPFAR prevention policy

HIV incidence amongst injecting drug users in St Petersburg near 5%, highest in speed users

Cost of treatment and care becoming sensitive issue for UK as NHS faces spending slow-down